These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand? Chen SS; Seliger SL; Fried LF Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549 [TBL] [Abstract][Full Text] [Related]
27. Endothelial damage and regeneration: the role of the renin-angiotensin-aldosterone system. Becher UM; Endtmann C; Tiyerili V; Nickenig G; Werner N Curr Hypertens Rep; 2011 Feb; 13(1):86-92. PubMed ID: 21108024 [TBL] [Abstract][Full Text] [Related]
28. [Dual blockade of the renin-angiotensin system]. Andersen NH; Mogensen CE Ugeskr Laeger; 2004 Oct; 166(43):3799-803. PubMed ID: 15544108 [No Abstract] [Full Text] [Related]
29. [Renin inhibition and the kidney]. Ecder T Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474 [TBL] [Abstract][Full Text] [Related]
30. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need? Lim S Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878 [TBL] [Abstract][Full Text] [Related]
31. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment. Ponticelli C; Cucchiari D J Nephrol; 2017 Apr; 30(2):155-157. PubMed ID: 28211033 [No Abstract] [Full Text] [Related]
32. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step? Hollenberg NK Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314 [TBL] [Abstract][Full Text] [Related]
33. Does direct inhibition bring direct benefit? Abe S; Taguchi I; Inoue T Circ J; 2012; 76(6):1326. PubMed ID: 22739081 [No Abstract] [Full Text] [Related]
34. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity. Dalla Vestra M; Simioni N; Masiero A Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162 [TBL] [Abstract][Full Text] [Related]
35. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy? Weber MA; Giles TD Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123 [TBL] [Abstract][Full Text] [Related]
36. Renin inhibition: what are the clinical perspectives? Hollenberg NK Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787 [TBL] [Abstract][Full Text] [Related]
37. Renin inhibition: the holy grail of renin-angiotensin system blockade? McInnes GT J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389 [No Abstract] [Full Text] [Related]
39. From black and white to shades of gray: race and renin-angiotensin system blockade. Havranek EP J Am Coll Cardiol; 2008 May; 51(19):1872-3. PubMed ID: 18466802 [No Abstract] [Full Text] [Related]
40. Can two be better than one? Dual RAS blockade in patients with type 2 diabetes and overt nephropathy in the age of ONTARGET and ALTITUDE. Lovshin JA; Cherney DZ Hypertens Res; 2014 Jan; 37(1):4-6. PubMed ID: 24026039 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]